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In 1995, the Expert Advisory Group on Cancer to the Chief Medical
Officers of England and Wales published recommendations (the
‘Calman–Hine’ Report) on the management of cancer (Expert
Advisory Group on Cancer, 1995). The report argued that, at that
time, patients were being admitted to units that were not adequately
equipped to provide the full range of diagnostic and therapeutic
interventions, with the consequence that the quality of care was
compromised, and varied substantially across the country. One of 
the principal problems identified was insufficient concentration of
service provision, so limiting the opportunity for clinical staff to sub-
specialize. 
Central to the conclusions of the Expert Advisory Group’s Report
is the recommendation to limit cancer surgery to site-specialized
‘high-volume’ consultants working in multi-disciplinary teams in
designated cancer units and centres. Research evidence of improved
outcomes in patients treated by specialist or high-volume consultants
exists for breast cancer, but is less clear for colorectal and ovarian
cancers (Sainsbury et al, 1995; Gillis and Hole, 1996). A number of
studies have explored the relationship between surgical volume of
work and outcome from colorectal cancer, but although variation in
practice and outcome have been observed (Fielding et al, 1980;
Phillips et al, 1984; McCardle and Hole, 1991; Mella et al, 1997) a
clear and consistent association with throughput is not apparent with
some studies suggesting a relationship (Hermanek and Hohenberger,
1996; Porter et al, 1998) and others not (Sagar et al, 1996; Parry 
et al, 1999). With regard to ovarian cancers, an association with
throughput again is not clear, although improved outcomes have
been noted among specialist gynaecologists compared to general
surgeons (Nguyen et al, 1993; Junor et al, 1994; Kehoe et al, 1994). 
Despite the availability of a robust evidence base, the
Calman–Hine Report advocated service centralization as a means
of improving patient outcome. Thus, if the recommendations have
been implemented successfully, we would have expected there
would have been more surgeons undertaking a sufficient volume
of work to maintain sub-specialization skills in 1997 than in 1992.
However, given the phased nature of the Calman–Hine implemen-
tation process with breast, colorectal and lung cancers being
chosen as the initial sites for service reorganization, followed more
recently by recommendations for the management of gynaecolog-
ical malignancies, it might be anticipated that sub-specialization
would have occurred at different speeds for different tumours. The
degree to which this has occurred is likely to be of central interest
to the new Commission for Health Improvement in their moni-
toring of progress towards the implementation of the recommen-
dations in the Calman–Hine Report. 
We have therefore analysed changing patterns for the surgical
management of breast, colorectal and ovarian cancer in the West
Midlands region during the period 1992–1997. Specifically the 2
questions addressed by the study are whether between 1992 and 1997
(i) an increasing proportion of cases were treated by ‘high-volume’
consultant firms; and (ii) fewer (and therefore fewer low-volume)
consultant firms were undertaking primary resective cancer 
surgery. 
METHODS 
Study setting and population 
We based our study on the West Midlands region of the NHS. The
region serves a population of 5.3 million residents which
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comprises more than 10% of the population of England and Wales.
The region’s demographic composition and health service provi-
sion is typical of England and Wales. 
Data abstraction and case definition 
We used the Hospital Episode Statistics (HES) dataset to identify
records of patients who (i) were admitted to NHS hospitals
between 01/04/92 and 31/03/97, (ii) had an admission diagnostic
code for breast, ovarian or colorectal cancer, and (iii) underwent a
surgical resection the nature of which was compatible with the
primary excision of the tumour. For example, for ovarian cancer
this included all excisions of the ovary, adnexae and uterus but
excluded non-specific laparotomy or stoma formation without
ovarian resection. We were unable to extend the study period
beyond 1997 due to changes in the HES dataset which precluded
identification of individual consultants. For all 3 sites, patients
managed non-surgically by radiotherapy and/or chemotherapy
only were excluded from the analysis. Details of the diagnostic
and procedural codes we used are shown in Table 1. For each case
included in the analysis, information on date of operation and
consultant code were abstracted from the HES dataset. 
Case volume definition and selection of thresholds 
We defined the surgical volume of each consultant firm as the
number of procedures which involved primary resection of the
tumour (Table 1) undertaken each year (1 April to 31 March). The
term ‘procedure’ is used throughout the text to refer to primary
resections. Throughput was calculated for the consultant firm
rather than individual clinician because HES only permits the
identification of the lead consultant responsible for care. 
For each site a series of throughput groups were created. For
breast cancer we defined a high-volume consultant firm after
reviewing the evidence on outcomes for surgery and taking into
account College and national recommendations on minimum
acceptable workloads for surgeons (BASO, 1995; Sainsbury et al,
1995). For colorectal and ovarian cancers, the literature was
reviewed for evidence of appropriate thresholds but no robust
information was available and thus we selected cut-offs that
reflected the incidence of disease. For breast and colorectal cancer
these were: less than 10 procedures per year, 10–29, 30–49, and 50
or more. For ovary the groups were: 1, 2–4, 5–9 and 10 or more
per year, reflecting the lower incidence of disease. The proportion
of cases managed by consultant firms undertaking different
volumes of work, and the number of consultant firms in each
throughput group were calculated for each year of the study. For
breast cancer high volume consultant firms were those under-
taking 30 or more procedures per year, for colorectal cancer the
threshold was 50 procedures, and for ovarian cancer 10 procedures
per year. 
Statistical analysis 
We used Excel and SPSS for Windows™ to store and analyse data.
A Chi-squared test for trend (ordered) was used to establish
whether there was a trend over time in the proportion of cases
treated by the high volume consultant firms. All tests of signifi-
cance were at the 5% two-sided level and were focussed on the
threshold for high-volume consultant firms to avoid multiple
testing. 
RESULTS 
Over the 5-year period, there were 26 351 admissions to hospital
with both a diagnostic code for breast cancer and an OPCS-coded
procedure in hospital, 14 227 of which had a surgical procedure
consistent with primary resection of their disease. The remaining
admissions were for radiotherapy, chemotherapy or procedures not
related to breast cancer. Of the admissions with a diagnosis of
colon or rectal cancer, 12 803 had a colonic or rectal resection.
There were 1326 excisions of the ovary on patients with ovarian
cancer (Table 1). 
Patient data 
Figures 1–3 show the proportion of cases each year who were
treated by consultant firms that undertook different volumes of
site-specific resective surgery. For breast cancer there is a clear
divergent trend between the groups over the 5-year period. The
Table 1 Diagnostic and procedural codes used to select cases of ovarian, colorectal and breast cancer which were treated by
potentially curative surgery, with numbers identified, 1992–97 
Breast cancer Colorectal cancer Ovarian cancer 
ICD-9 diagnoses 174 153 183 
154
ICD-10 diagnoses C50* C18* C56X
C19X C57
C20X
C21*
OPCS procedure codes B27*–B28* H04*–H17* Q07*–Q08* 
H33*–H34* Q22*–Q24*
H40*–H41*
Number of admissions with  26 351 26 265 5763
diagnosis of breast cancer, and 
any procedure code
Number of admissions with  14 227 12 803 1326 
diagnosis, and a procedure code
for resective breast surgery1310 K Jolly et al 
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proportion of cases managed by the highest volume (> 50 cases)
consultant firms increased from 52% in 1992/93 to 78% in
1996/97 with a concomitant decrease in the proportion of cases
treated by consultant firms operating on < 10, 10–29 and 30–49
cases per year. A significant but much less marked trend was noted
for ovarian cancer with a gradual increase, but still a minority, of
higher-volume cases. For colorectal cancer however the picture
was mixed. There was an increase in the proportion of cases
managed by both the highest (50 cases or more) and lowest (< 10)
volume consultant firms, with workload shifting from those firms
managing 10–49 cases per year. 
The overall proportion of cases treated by high-volume consul-
tant firms was substantially greater for breast cancer (90% in
1996/97) than for either colorectal (27%) or ovarian (11%)
disease. However, for all 3 sites, the proportion of cases managed
by a high-volume consultant firm increased significantly over 
the study period (breast c2
(trend)(1 df) = 438; P < 0.001; colorectal
c2
(trend)(1 df) = 58; P < 0.001; and ovary c2
(trend)(1 df) = 15; P < 0.001). 
Consultant firm data 
Table 2 shows details of the number of consultant firms that under-
took differing volumes of resective surgery annually. The overall
numbers of consultant firms undertaking breast cancer surgery
reduced in 1995–96 and then more markedly in 1996–97. In
contrast the numbers of consultant firms which undertook surgical
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Figure 1 Proportion of breast cancer operations carried out by consultant firms undertaking different volumes of breast surgery
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Figure 2 Proportion of colorectal cancer operations carried out by consultant firms undertaking different volumes of colorectal cancer surgeryCancer surgery sub-specialization 1311
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resections for colorectal and ovarian cancer increased over the
period. For all 3 cancers however, a large proportion of consultant
firms was still undertaking very low numbers of procedures at the
end of the 5-year period. In ovarian cancer in particular, in excess
of 80% of ovarian cancer consultant firms who undertake ovarian
cancer surgery at all, do less than 5 ovarian cancer resections each
per year. 
DISCUSSION 
The results from this study suggest that between 1992 and 1997,
the proportion of cancer cases who were treated by consultant
firms undertaking high volumes of work increased significantly.
We would expect this to translate into better outcomes for patients.
However, the patterns of change were not the same across cancer
sites. In breast cancer there was a clear shift in patient workload to
the high-volume consultant firms from those undertaking primary
resections less frequently. A similar pattern was noted for ovary
although it was considerably less marked, and even by the end of
the study period the proportion of cases managed by a high-
volume consultant firm was only 11%. For colorectal cancer 
high-volume consultant firms undertook an increasing proportion
of caseload. However an increase in the proportion of cases
managed by low-volume consultant firms was also noted. The
Table 2 Number of consultant firms undertaking differing volumes of breast, colorectal and ovarian cancer resections, 1992–97 
Number of consultants undertaking different annual volumes of cancer surgery 
Annual number 
of cancer resection 1992–3 % 1993–4 % 1994–5 % 1995–6 % 1996–7 % 
Breast 
<10 47 42 56 50 70 60 57 54 41 49 
10–29 32 29 29 26 16 14 16 15 10 12 
30–49 16 14 8 7 10 9 5 5 9 11 
50+ 17 15 20 18 21 18 27 26 24 29 
total 112 100 113 100 117 100 105 100 84 100 
Colorectal 
<10 62 42 56 38 74 47 78 48 101 56 
10–29 52 35 64 43 56 35 57 35 52 29 
30–49 26 18 20 14 20 13 16 10 17 9 
50+ 7 5 8 5 8 5 10 6 10 6 
total 147 100 148 100 158 100 161 100 180 100 
Ovary 
1 3 64 0 4 04 4 3 84 6 4 7 4 4 4 14 1  
2–4 41 46 32 35 27 33 40 37 42 42 
5–9 12 13 17 19 15 18 17 16 15 15 
1 0 + 11 22 22 4 4 22  
total 90 100 91 100 82 100 108 100 100 100 
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evidence to support an association between throughput and
outcome is stronger for breast cancer (Sainsbury et al, 1995) than
for either colorectal or ovarian tumours. There is some suggestion
in the literature that any association between consultant throughput
and outcome is more marked for rectal than for colon cancer
(Hermanek and Hohenberger, 1996; Porter et al, 1998), although 
a more recent study from the United States has suggested that at 
a hospital level, increased throughput is also associated with
improved outcome from colon cancer (Schrag et al, 2000).
Although cognisant of the potential advantages of considering
colon and rectal cancers separately, we made no attempt to dissag-
gregate tumours of the large bowel into ‘colon’ and ‘rectum’
because the Calmin–Hine recommendations treat colorectal cancer
as a single disease entity. 
This study has described management trends in a population of
5.3 million residents with demographic characteristics and service
provision similar to elsewhere in England. However, one factor
which might affect the validity of our findings is the completeness
and accuracy of the HES data. This has been studied in the past
with the most recent figures of 98% completeness for key fields
(McKee, 1993). Information on the West Midlands HES reported a
1.4% non-completion rate for the main diagnostic codes in
1994–95 (Wilson, 1997). Approximately half of all the admissions
in this series with a diagnosis of breast, colorectal or ovarian
cancer had no associated resective procedure. It is probable that
these admissions were for non-surgical reasons. However, it is also
possible that the absence of a surgical procedure reflects incom-
plete coding within Trusts. To estimate whether this potential
coding deficiency could affect our findings, we compared the
number of cases in our hospitalized series with incidence data
from the West Midlands Regional Cancer Registry. This data
suggests that we were successful in identifying at least 89% of
breast, 82% of colorectal and 71% of ovarian cancer resections.
Thus we believe that we identified the majority of resective proce-
dures carried out on patients with these cancers. If coding deficien-
cies have led to an under-ascertainment of cases then we do not
believe there is a systematic bias in our results, as the proportion of
cancer cases with procedure codes in our dataset does not vary
significantly between high- and low-volume hospitals. 
In this study we used a tight definition for the surgical proce-
dure, and thus also for the estimation of volume of work. To be
included in the analysis cases had to have an OPCS code consis-
tent with the admission diagnosis and with resection of the tumour.
In this way we believe that we have only identified the primary
surgical procedure. However two misclassification errors are
possible. Firstly, it is inevitable that we will have included some
procedures for tumour recurrence and not primary resection. If
resection of recurrent disease is more likely to be undertaken by a
specialist consultant firm, then the inclusion of some of these cases
in our series will have overestimated the throughput of high-
volume relative to lower-volume consultant firms, i.e. the increase
in proportion of cases managed by high-volume consultant firms
could be due to change in referral pattern for recurrent rather than
primary disease. Secondly, we will have underestimated the total
amount of cancer surgery done by consultant firms, as a proportion
of cases will present at an advanced stage and be unsuitable for
resective surgery. If the proportion of advanced, non-resectable
cases is greater among the workload of low-volume surgeons 
then the overall shift from low to high groups reported here 
will, in reality, be less marked and the proportion of cases 
seen by high-volume consultant firms over-estimated, i.e. we 
have over-estimated the effectiveness of the implementation
process. 
The data used in this study were derived from the HES dataset.
We were unable to extend the study period beyond 1997 due to
changes in the HES dataset which precluded identification of indi-
vidual consultants. An option to circumvent this difficulty would
be to use probablistic linkage techniques to link HES data with that
of the regional cancer registry to ascertain the identity of the
consultant responsible for care (Pollock and Vickers, 1998). However
such linkage requires information of explicit patient identifiers
(date of birth, sex and postcode address). During the period when
this study was being undertaken, there were substantial concerns
with regard to the use of cancer registry data and patient consent –
concerns that have only been put on hold at present due to an
interim (and temporary) statement from the General Medical
Council. In view of this, linkage between the HES dataset and
information held by the regional cancer registry was not feasible. 
The Calman–Hine report was published in 1995, with national
guidance on the management of breast and colorectal cancers
produced in 1995, 1996 and 1997 (BASO, 1995; Royal College of
Surgeons, 1996; NHS Executive, 1997). High-volume consultant
firms now manage over 90% of breast cancer cases, and there are
clear and consistent shifts in workload from low- to high-volume
consultant firms. This, we believe is due in part to the appointment
of specialist breast surgeons in the early 1990s even before the
implementation of Calman–Hine, and also to the elective nature of
breast cancer surgery. In contrast, about one-third of patients with
colorectal cancer present non-electively, often with bowel obstruc-
tion that requires immediate surgery by the surgical team on-call.
Thus although there is evidence of a shift in workload from
medium- to high-volume consultant firms (Figure 2) the propor-
tion of cases treated by very low-volume consultant firms has also
increased. The increase in the numbers of consultant firms doing
very low annual volumes of resective surgery noted in this study
may therefore have arisen as a consequence of the expansion of
consultant numbers. If this is the case, and the cases managed by
very low-volume consultant firms are emergencies, then to achieve
a reduction in the proportion of colorectal cancer cases managed
by very low-volume consultant firms would necessitate a reorgan-
ization of on-call arrangements or the time of surgery delayed until
the specialist colorectal cancer surgeon is available. This is already
being practiced in some hospitals nationally. Further work to
ascertain whether the low-volume surgery is made up of emer-
gency cases would be informative. 
The comparative rareness of ovarian cancer necessitates referral
of all cases to a limited number of sub-regional specialists working
in cancer centres, a process advocated by the recently published
guidelines on the management of gynaecological cancers (NHS
Executive, 1999). This is the first cancer site which has required a
solution beyond the reorganization of referral patterns within an
individual hospital. It is not surprising therefore that up until the
present, although some shifts in workload patterns have been
noted, only a minority of cases have been treated by high-volume
consultant firms. Furthermore gynaecological cancers were not
among the initial tranche of cancers targeted by the Calman–Hine
reorganization process and guidance for the management of
gynaecological cancers has only been produced within the last 12
months. It is unsurprising therefore that only limited progress has
been made. However, as with other cancer sites, for example head
and neck and upper gastrointestinal disease, the implementation of
the Calman–Hine recommendation for gynaecological cancersCancer surgery sub-specialization 1313
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requires reorganization and changes in referral patterns not only
within but also between Trusts. This process has already begun in
the West Midlands region with the establishment of cancer
networks. Given the need to monitor progress towards these
service delivery goals, it is unfortunate that since 1997 information
on consultant identity is no longer routinely available with the
HES activity data in the West Midlands. The methods used in this
study therefore cannot be replicated in future to explore subse-
quent trends in subspecialization. The importance of robust
systems for the monitoring of cancer care need to be addressed by
the Centre for Health Improvement, and other methods including
the use of cancer registry data, explored. This later approach
would have the advantage of being based on patients, rather than
activity data and contains information on outcome, which could
make an important contribution to monitoring cancer services. 
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